"Our basic drugs in the service of humanity worldwide"
Company
About Company
Mission & Vision
Quality Policy
Leadership
Plant & Facilities
Products
APIs
Drug Intermediates
Fine Chemicals
R&D
Contract Manufacturing
Investors
Shareholder Information
Corporate Governance
Financial Information
General Meetings
Regulation 46
Careers
Company
About Company
Mission & Vision
Quality Policy
Leadership
Plant & Facilities
Products
APIs
Drug Intermediates
Fine Chemicals
R&D
Contract Manufacturing
Investors
Shareholder Information
Corporate Governance
Financial Information
General Meetings
Regulation 46
Careers
Contact Us
Corporate Updates
Home
»
Corporate Updates
Shareholder Information
Corporate Information
Shareholding pattern
RTA details
KYC Forms for Shareholders
Corporate Governance
Corporate Updates
Policies
Board & Committee Composition
Financial Information
Financial Results
Board Meeting Intimation
Board Meeting Outcome
General Meetings
Annual Report
Annual Return
Voting Results
AGM/EGM proceedings
AGM/EGM Notice
Regulation 46
Regulation 46
Select Year
2025-26
2025-26
Update on Project under revised schedule M
Special Window for Transfer and Dematerialisation of Physical Securities
